Eli Lilly's TuneLab is a significant advance that should lower the barrier to entry for smaller biotechs to access state-of-the-art AI, while creating a flywheel of improvements that no single company could achieve on its own.
Risk and Disclaimer:The content shared by the author represents only their personal views and does not reflect the position of CoinWorldNet (币界网). CoinWorldNet does not guarantee the truthfulness, accuracy, or originality of the content. This article does not constitute an offer, solicitation, invitation, recommendation, or advice to buy or sell any investment products or make any investment decisions
No Comments
edit
comment
collection
like
share